Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin
NCT ID: NCT00412269
Last Updated: 2016-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
1998-02-28
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Dietary Manipulation on Metabolism in Healthy Adults
NCT00476125
Effect of the Glycemic Index of Diet on Metabolic and Reproductive Parameters in Overweight and Obese Infertile Women
NCT02416960
Insulin Sensitivity After Breast Cancer
NCT05010356
Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients
NCT00569959
Expression of Longevity Genes in Response to Extended Fasting
NCT01059760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will address 4 general hypotheses:
* Menopause increases both total and visceral abdominal fat
* Changes in body composition and body weight at menopause are mediated, at least in part by changes in 24-hour energy expenditure and/or food intake
* Menopause results in decreased insulin sensitivity that may predispose certain women to develop diabetes later in life
* African-American women may respond to the shifts in reproductive hormones at menopause differently than caucasian women.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index 25-40
* Normal oral glucose tolerance test by National Diabetes Data Group criteria
* Premenopausal, defined by FSH levels \<30mIU/ml and at least 5 menstrual periods in the last 6 months
* Able to confirm ethnic heritage of past 2 generations in family
Exclusion Criteria
* regular use of medications that influence glucose tolerance
* use of oral contraceptives within the past 6 months
* history of myocardial infarction or significant coronary vascular disease or stroke
* history of endocrine, kidney, or liver disease or malignancy
* any psychopathology, including eating disorders, substance abuse, and major depression
* unable to complete longitudinal study commitment, including anticipating moving out of the area within the next 5 years.
47 Years
52 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donna H. Ryan, MD
Professor, Adjunct
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven R Smith, M. D.
Role: PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008 Jun;32(6):949-58. doi: 10.1038/ijo.2008.25. Epub 2008 Mar 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 97022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.